Stock information

VALBIOTIS specializes in developing innovative nutrition solutions designed to prevent cardiometabolic diseases and provide nutritional support for patients. Its products are made for manufacturers in the agro-food and pharmaceutical industries. VALBIOTIS particularly focuses on solutions to prevent type 2 diabetes, NASH (nonalcoholic steatohepatitis), obesity and cardiovascular diseases.
Valbiotis has been listed on Euronext Growth since 7 June 2017.

• Label: Valbiotis
• Mnemonic: ALVAL
• ISIN Code: FR 0013254851
• PEA PME eligible: Oui
• Trading Market:
  • ALTERNEXT ALLSHARE
  • NEXT BIOTECH
• Total number of shares: 7,216,500